Next earnings date: 1 Sep 2025
Aspen Pharmacare Holdings Limited – OTC:APNHY
Aspen Pharmacare Holdings Limited stock price today
$6.59
-2.79
-29.74%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 1 hour
Aspen Pharmacare Holdings Limited stock price monthly change
-25.73%
month
Aspen Pharmacare Holdings Limited stock price quarterly change
-25.73%
quarter
Aspen Pharmacare Holdings Limited stock price yearly change
-14.96%
year
Aspen Pharmacare Holdings Limited key metrics
Market Cap | 3.84B |
Enterprise value | 101.90B |
P/E | 17.65 |
EV/Sales | 2.27 |
EV/EBITDA | 9.89 |
Price/Sales | 1.73 |
Price/Book | 0.91 |
PEG ratio | N/A |
EPS | 12.70 |
Revenue | 40.78B |
EBITDA | 9.95B |
Income | 5.68B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 9.85% |
Oper. margin | 15.65% |
Gross margin | 43.43% |
EBIT margin | 15.65% |
EBITDA margin | 24.41% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAspen Pharmacare Holdings Limited stock price history
Aspen Pharmacare Holdings Limited stock forecast
Aspen Pharmacare Holdings Limited financial statements
| Mar 2022 | 9.61B | 1.56B | 16.27% |
|---|---|---|---|
| Jun 2022 | 9.61B | 1.56B | 16.27% |
| Mar 2023 | 10.77B | 1.27B | 11.85% |
| Jun 2023 | 10.77B | 1.27B | 11.85% |
| 2026 | 2.89B | 509.41M | 17.6% |
|---|---|---|---|
| 2027 | 3.61B | 0 |
Analysts Price target
Financials & Ratios estimates
| 2024-09-03 | 0.568 | 0.124 |
|---|
2.13%
Yield TTM
| Payout ratio | 34.63% |
|---|
| 2020 | |
|---|---|
| 2021 | |
| 2022 | 1.81% |
| 2023 | 1.78% |
| 2024 | 1.52% |
| Sep 2022 | 120576000000 | 45.36B | 37.62% |
|---|---|---|---|
| Dec 2022 | 7086453129 | 2.66B | 37.62% |
| Mar 2023 | 134284000000 | 48.04B | 35.78% |
| Jun 2023 | 7108264408 | 2.54B | 35.78% |
| Mar 2022 | 1.80B | 198.5M | -2.31B |
|---|---|---|---|
| Jun 2022 | 1.80B | 198.5M | -2.31B |
| Mar 2023 | 1.90B | -916.5M | -300.5M |
| Jun 2023 | 1.90B | -916.5M | -300.5M |
Aspen Pharmacare Holdings Limited alternative data
| Aug 2023 | 8,580 |
|---|---|
| Sep 2023 | 8,580 |
| Oct 2023 | 8,580 |
| Nov 2023 | 8,612 |
| Dec 2023 | 8,612 |
| Jan 2024 | 8,612 |
| Feb 2024 | 8,612 |
| Mar 2024 | 8,612 |
| Apr 2024 | 8,612 |
| May 2024 | 8,612 |
| Jun 2024 | 8,612 |
| Jul 2024 | 8,612 |
Aspen Pharmacare Holdings Limited other data
Wednesday, 4 September 2024 | ||
| Aspen Pharmacare Holdings Limited (APNHF) Q4 2024 Earnings Call Transcript | seekingalpha.com | |
Thursday, 31 August 2023 | ||
| Aspen Pharmacare Holdings Limited (APNHF) Q4 2023 Earnings Call Transcript | Seeking Alpha | |
Thursday, 1 September 2022 | ||
| Aspen Pharmacare Holdings Limited (APNHF) Q4 2022 Earnings Call Transcript | Seeking Alpha | |
Monday, 11 July 2022 | ||
| New Strong Sell Stocks for July 11th | Zacks Investment Research | |
Tuesday, 22 March 2022 | ||
| New Strong Sell Stocks for March 22nd | Zacks Investment Research | |
Thursday, 10 March 2022 | ||
| Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript | Seeking Alpha | |
Monday, 28 February 2022 | ||
| New Strong Sell Stocks for February 28th | Zacks Investment Research |
-
What's the price of Aspen Pharmacare Holdings Limited stock today?
One share of Aspen Pharmacare Holdings Limited stock can currently be purchased for approximately $6.59.
-
When is Aspen Pharmacare Holdings Limited's next earnings date?
Aspen Pharmacare Holdings Limited is estimated to report earnings on Monday, 1 Sep 2025.
-
Does Aspen Pharmacare Holdings Limited pay dividends?
Yes, Aspen Pharmacare Holdings Limited pays dividends and its trailing 12-month yield is 2.13% with 35% payout ratio. The last Aspen Pharmacare Holdings Limited stock dividend of undefined was paid on 26 Sep 2025.
-
How much money does Aspen Pharmacare Holdings Limited make?
Aspen Pharmacare Holdings Limited has a market capitalization of 3.84B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1851.77% to 44.71B US dollars. Aspen Pharmacare Holdings Limited earned 4.4B US dollars in net income (profit) last year or $0.12 on an earnings per share basis.
-
What is Aspen Pharmacare Holdings Limited's stock symbol?
Aspen Pharmacare Holdings Limited is traded on the OTC under the ticker symbol "APNHY".
-
What is Aspen Pharmacare Holdings Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Aspen Pharmacare Holdings Limited?
Shares of Aspen Pharmacare Holdings Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Aspen Pharmacare Holdings Limited have?
As Jul 2024, Aspen Pharmacare Holdings Limited employs 8,612 workers.
-
When Aspen Pharmacare Holdings Limited went public?
Aspen Pharmacare Holdings Limited is publicly traded company for more then 15 years since IPO on 5 Apr 2010.
-
What is Aspen Pharmacare Holdings Limited's official website?
The official website for Aspen Pharmacare Holdings Limited is aspenpharma.com.
-
How can i contact Aspen Pharmacare Holdings Limited?
Aspen Pharmacare Holdings Limited can be reached via phone at +27 31 580 8600.
Aspen Pharmacare Holdings Limited company profile:
Aspen Pharmacare Holdings Limited
aspenpharma.comExchange:
OTC
Full time employees:
8,580
Industry:
Drug Manufacturers—Specialty & Generic
Sector:
Healthcare
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Aspen Place
Durban,
Durban,
:
ISIN: US04530Y1064
CUSIP: 04530Y106
